• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合自动机方法在人工胰腺系统中用于监测患者回路。

A Hybrid Automata Approach for Monitoring the Patient in the Loop in Artificial Pancreas Systems.

机构信息

Department of Electrical, Electronic and Automatic Engineering, University of Girona, 17004 Girona, Spain.

Automatic Control Department-Campus de Terrassa, Universitat Politècnica de Catalunya (UPC), 08222 Terrassa, Spain.

出版信息

Sensors (Basel). 2021 Oct 27;21(21):7117. doi: 10.3390/s21217117.

DOI:10.3390/s21217117
PMID:34770425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8587755/
Abstract

The use of automated insulin delivery systems has become a reality for people with type 1 diabetes (T1D), with several hybrid systems already on the market. One of the particularities of this technology is that the patient is in the loop. People with T1D are the plant to control and also a plant operator, because they may have to provide information to the control loop. The most immediate information provided by patients that affects performance and safety are the announcement of meals and exercise. Therefore, to ensure safety and performance, the human factor impact needs to be addressed by designing fault monitoring strategies. In this paper, a monitoring system is developed to diagnose potential patient modes and faults. The monitoring system is based on the residual generation of a bank of observers. To that aim, a linear parameter varying (LPV) polytopic representation of the system is adopted and a bank of Kalman filters is designed using linear matrix inequalities (LMI). The system uncertainty is propagated using a zonotopic-set representation, which allows determining confidence bounds for each of the observer outputs and residuals. For the detection of modes, a hybrid automaton model is generated and diagnosis is performed by interpreting the events and transitions within the automaton. The developed system is tested in simulation, showing the potential benefits of using the proposed approach for artificial pancreas systems.

摘要

自动化胰岛素输送系统已成为 1 型糖尿病 (T1D) 患者的现实选择,已有多种混合系统上市。这项技术的一个特点是患者处于反馈回路中。T1D 患者既是控制者,也是操作人员,因为他们可能需要向控制回路提供信息。患者提供的最直接影响性能和安全性的信息是用餐和运动的通知。因此,为了确保安全和性能,需要通过设计故障监测策略来解决人为因素的影响。本文开发了一种监测系统,用于诊断潜在的患者模式和故障。监测系统基于观测器库的残差生成。为此,采用了系统的线性参数时变 (LPV) 多面体表示,并使用线性矩阵不等式 (LMI) 设计了卡尔曼滤波器库。使用 zonotopic-set 表示法传播系统不确定性,这允许确定每个观测器输出和残差的置信区间。为了检测模式,生成了混合自动机模型,并通过解释自动机中的事件和转换来进行诊断。所开发的系统在仿真中进行了测试,展示了在人工胰腺系统中使用所提出方法的潜在优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/d47de44b5c7e/sensors-21-07117-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/fa709ad3f421/sensors-21-07117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/dd2feb1e0331/sensors-21-07117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/c258097b5b30/sensors-21-07117-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/bdf9504ebb19/sensors-21-07117-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/7cf33b39e432/sensors-21-07117-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/73d8acb6dc96/sensors-21-07117-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/d47de44b5c7e/sensors-21-07117-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/fa709ad3f421/sensors-21-07117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/dd2feb1e0331/sensors-21-07117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/c258097b5b30/sensors-21-07117-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/bdf9504ebb19/sensors-21-07117-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/7cf33b39e432/sensors-21-07117-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/73d8acb6dc96/sensors-21-07117-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61dc/8587755/d47de44b5c7e/sensors-21-07117-g009.jpg

相似文献

1
A Hybrid Automata Approach for Monitoring the Patient in the Loop in Artificial Pancreas Systems.混合自动机方法在人工胰腺系统中用于监测患者回路。
Sensors (Basel). 2021 Oct 27;21(21):7117. doi: 10.3390/s21217117.
2
Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives.考虑人为因素的自动化胰岛素输送容错策略:当前和未来的观点。
J Diabetes Sci Technol. 2021 Nov;15(6):1224-1231. doi: 10.1177/19322968211029297. Epub 2021 Jul 21.
3
Human-in-the-Loop Insulin Dosing.人在回路胰岛素给药。
J Diabetes Sci Technol. 2021 May;15(3):699-704. doi: 10.1177/1932296819891177. Epub 2019 Dec 4.
4
Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.DIY 人工胰腺系统:医疗专业人员新兴证据和见解综述。
J Diabetes Sci Technol. 2020 Sep;14(5):868-877. doi: 10.1177/1932296819894296. Epub 2019 Dec 17.
5
[What is the current state of the artificial pancreas in diabetes care?].[糖尿病护理中人工胰腺的当前状况如何?]
Internist (Berl). 2020 Jan;61(1):102-109. doi: 10.1007/s00108-019-00713-y.
6
Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events.区域模型预测控制:一种将高血糖和低血糖事件降至最低的策略。
J Diabetes Sci Technol. 2010 Jul 1;4(4):961-75. doi: 10.1177/193229681000400428.
7
Adaptive and Personalized Plasma Insulin Concentration Estimation for Artificial Pancreas Systems.用于人工胰腺系统的自适应和个性化血浆胰岛素浓度估计
J Diabetes Sci Technol. 2018 May;12(3):639-649. doi: 10.1177/1932296818763959. Epub 2018 Mar 23.
8
How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).从何而来,路在何方:人工胰腺系统(自动胰岛素输送系统)的未来。
J Diabetes Sci Technol. 2021 Nov;15(6):1258-1261. doi: 10.1177/19322968211027558. Epub 2021 Jul 5.
9
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.使用闭环自动化胰岛素输送(人工胰腺)和恩格列净减少 1 型糖尿病患者对碳水化合物计数的需求:一项随机、对照、非劣效、交叉先导试验。
Diabetes Obes Metab. 2021 Jun;23(6):1272-1281. doi: 10.1111/dom.14335. Epub 2021 Feb 28.
10
Diabetes technology and treatments in the paediatric age group.儿科年龄组的糖尿病技术与治疗
Int J Clin Pract Suppl. 2011 Feb(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x.

本文引用的文献

1
Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives.考虑人为因素的自动化胰岛素输送容错策略:当前和未来的观点。
J Diabetes Sci Technol. 2021 Nov;15(6):1224-1231. doi: 10.1177/19322968211029297. Epub 2021 Jul 21.
2
Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes.胰岛素门冬的三种不同制剂的药代动力学和药效学:1 型糖尿病男性的随机、双盲、交叉研究。
Diabetes Care. 2021 Feb;44(2):448-455. doi: 10.2337/dc20-1017. Epub 2020 Dec 16.
3
Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes.
人工胰腺的碳水化合物建议性能在 1 型糖尿病中的未通知和通知的运动中。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):55-63. doi: 10.1210/clinem/dgaa562.
4
Dynamic Rule-Based Algorithm to Tune Insulin-on-Board Constraints for a Hybrid Artificial Pancreas System.基于动态规则的算法,用于调整混合人工胰腺系统的胰岛素负荷限制。
J Healthc Eng. 2020 Jan 11;2020:1414597. doi: 10.1155/2020/1414597. eCollection 2020.
5
The Evolution of Insulin and How it Informs Therapy and Treatment Choices.胰岛素的发展历程及其对治疗选择的启示。
Endocr Rev. 2020 Oct 1;41(5):733-55. doi: 10.1210/endrev/bnaa015.
6
Human-in-the-Loop Insulin Dosing.人在回路胰岛素给药。
J Diabetes Sci Technol. 2021 May;15(3):699-704. doi: 10.1177/1932296819891177. Epub 2019 Dec 4.
7
Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.门冬胰岛素速效:药代动力学和药效学特性及临床后果的综述。
Clin Pharmacokinet. 2020 Feb;59(2):155-172. doi: 10.1007/s40262-019-00834-5.
8
Parallel Control of an Artificial Pancreas with Coordinated Insulin, Glucagon, and Rescue Carbohydrate Control Actions.具有胰岛素、胰高血糖素和急救碳水化合物控制协同作用的人工胰腺并行控制
J Diabetes Sci Technol. 2019 Nov;13(6):1026-1034. doi: 10.1177/1932296819879093. Epub 2019 Oct 20.
9
Detection of Insulin Pump Malfunctioning to Improve Safety in Artificial Pancreas Using Unsupervised Algorithms.使用无监督算法检测胰岛素泵故障以提高人工胰腺的安全性
J Diabetes Sci Technol. 2019 Nov;13(6):1065-1076. doi: 10.1177/1932296819881452. Epub 2019 Oct 14.
10
MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.美敦力 670G 混合闭环人工胰腺系统治疗 1 型糖尿病:安全性和有效性概述。
Expert Rev Med Devices. 2019 Oct;16(10):845-853. doi: 10.1080/17434440.2019.1670639. Epub 2019 Sep 30.